Literature DB >> 21556489

Health-related quality of life in patients with Chagas disease.

Bruna Guimarães Oliveira1, Mery Natali Silva Abreu, Claudia Drummond Guimarães Abreu, Manoel Otavio da Costa Rocha, Antonio Luiz Ribeiro.   

Abstract

INTRODUCTION: Chagas disease (ChD) is a chronic illness related to significant morbidity and mortality that can affect the quality of life (QoL) of infected patients. However, there are few studies regarding QoL in ChD. The objectives of this study are to construct a health-related QoL (HRQoL) profile of ChD patients and compare this with a non-ChD (NChD) group to identify factors associated with the worst HRQoL scores in ChD patients.
METHODS: HRQoL was investigated in 125 patients with ChD and 21 NChD individuals using the Medical Outcomes Study 36-item Short-Form (SF-36) and the Minnesota Living with Heart Failure Questionnaire (MLWHFQ). Patients were submitted to a standard protocol that included clinical examination, ECG, Holter monitoring, Doppler echocardiogram and autonomic function tests.
RESULTS: HRQoL scores were significantly worse among the ChD group compared to the NChD group in the SF-36 domains of physical functioning and role-emotional and in the MLWHFQ scale. For the ChD group, univariate analysis showed that HRQoL score quartiles were associated with level of education, sex, marital status, use of medication, functional classification and cardiovascular and gastrointestinal symptoms. In the multivariate analysis, female sex, fewer years of education, single status, worst functional classification, presence of cardiovascular and gastrointestinal symptoms, associated illnesses, Doppler echocardiographic abnormalities and ventricular arrhythmia detected during Holter monitoring were predictors of lower HRQoL scores.
CONCLUSIONS: ChD patients showed worse HRQoL scores compared to NChD. For the ChD group, sociodemographic and clinical variables were associated with worst scores.

Entities:  

Mesh:

Year:  2011        PMID: 21556489     DOI: 10.1590/s0037-86822011005000002

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  8 in total

1.  The prognostic value of health-related quality of life in patients with Chagas heart disease.

Authors:  Henrique Silveira Costa; Márcia Maria Oliveira Lima; Pedro Henrique Scheidt Figueiredo; Ana Thereza Chaves; Maria Carmo Pereira Nunes; Manoel Otávio da Costa Rocha
Journal:  Qual Life Res       Date:  2018-08-30       Impact factor: 4.147

2.  Impact of pharmaceutical care on the quality of life of patients with heart failure due to chronic Chagas disease: Randomized clinical trial.

Authors:  Mayara da Costa Chambela; Mauro Felippe Felix Mediano; Fernanda Martins Carneiro; Roberto Rodrigues Ferreira; Mariana Caldas Waghabi; Verônica Gonçalves Mendes; Luciano de Souza Oliveira; Marcelo Teixeira de Holanda; Andréa Silvestre de Sousa; Andréa Rodrigues da Costa; Sérgio Salles Xavier; Gilberto Marcelo Sperandio da Silva; Roberto Magalhães Saraiva
Journal:  Br J Clin Pharmacol       Date:  2019-11-27       Impact factor: 4.335

3.  Impact of pharmaceutical care on the quality of life of patients with Chagas disease and heart failure: randomized clinical trial.

Authors:  Gilberto M Sperandio da Silva; Mayara C Chambela; Andrea S Sousa; Luiz Henrique C Sangenis; Sergio S Xavier; Andréa R Costa; Pedro Emmanuel A A Brasil; Alejandro M Hasslocher-Moreno; Roberto M Saraiva
Journal:  Trials       Date:  2012-12-27       Impact factor: 2.279

4.  Factors associated with quality of life in patients with Chagas disease: SaMi-Trop project.

Authors:  Nayara Dornela Quintino; Ester Cerdeira Sabino; José Luiz Padilha da Silva; Antonio Luiz Pinho Ribeiro; Ariela Mota Ferreira; Gabriela Lemes Davi; Claudia Di Lorenzo Oliveira; Clareci Silva Cardoso
Journal:  PLoS Negl Trop Dis       Date:  2020-05-27

5.  The health-related quality of life in patients with Chagas disease: the state of the art.

Authors:  Igor Lucas Geraldo Izalino de Almeida; Luciano Fonseca Lemos de Oliveira; Pedro Henrique Scheidt Figueiredo; Rafael Dias de Brito Oliveira; Thayrine Rosa Damasceno; Whesley Tanor Silva; Lucas Frois Fernandes de Oliveira; Matheus Ribeiro Ávila; Vanessa Pereira Lima; Ana Thereza Chaves Lages; Mauro Felippe Felix Mediano; Manoel Otávio Costa Rocha; Henrique Silveira Costa
Journal:  Rev Soc Bras Med Trop       Date:  2022-03-14       Impact factor: 1.581

Review 6.  Quality of life in patients with Chagas disease and the instrument used: an integrative review.

Authors:  Nayara Ragi Baldoni; Nayara Dornela Quintino; Geisa Cristina Silva Alves; Claudia Di Lorenzo Oliveira; Ester Cerdeira Sabino; Antonio Luiz Pinho Ribeiro; Clareci Silva Cardoso
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2021-06-18       Impact factor: 2.169

7.  Assessment of Functional Capacity in Chagas Heart Disease by Incremental Shuttle Walk Test and its Relation to Quality-of-Life.

Authors:  Henrique Silveira Costa; Rafael Leite Alves; Stela Alves da Silva; Maria Clara Noman Alencar; Maria do Carmo Pereira Nunes; Márcia Maria Oliveria Lima; Manoel Otávio da Costa Rocha
Journal:  Int J Prev Med       Date:  2014-02

8.  Prevalence and determinants of depressive symptoms in patients with Chagas cardiomyopathy and predominantly preserved cardiac function.

Authors:  Whesley Tanor Silva; Matheus Ribeiro Ávila; Lucas Frois Fernandes de Oliveira; Pedro Henrique Scheidt Figueiredo; Vanessa Pereira Lima; Alessandra de Carvalho Bastone; Fábio Silva Martins da Costa; Mauro Felippe Felix Mediano; Henrique Silveira Costa; Manoel Otávio da Costa Rocha
Journal:  Rev Soc Bras Med Trop       Date:  2020-11-06       Impact factor: 1.581

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.